Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal pigment epithelial cell | 3 studies | 54% ± 24% |
Insufficient scRNA-seq data for expression of SFRP5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5846.48 | 328 / 328 | 87% | 84.39 | 154 / 178 |
intestine | 90% | 2163.83 | 865 / 966 | 21% | 4.59 | 110 / 527 |
stomach | 69% | 713.38 | 247 / 359 | 34% | 4.57 | 98 / 286 |
liver | 59% | 337.93 | 134 / 226 | 37% | 49.53 | 150 / 406 |
prostate | 60% | 538.86 | 146 / 245 | 30% | 1.49 | 152 / 502 |
esophagus | 64% | 987.26 | 924 / 1445 | 21% | 2.16 | 39 / 183 |
adrenal gland | 28% | 252.59 | 73 / 258 | 54% | 71.58 | 125 / 230 |
lung | 13% | 77.80 | 78 / 578 | 43% | 3.37 | 497 / 1155 |
ovary | 4% | 18.20 | 8 / 180 | 51% | 5.71 | 219 / 430 |
heart | 52% | 2553.04 | 449 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 46% | 3.70 | 37 / 80 |
skin | 19% | 86.21 | 352 / 1809 | 26% | 5.85 | 123 / 472 |
bladder | 33% | 190.05 | 7 / 21 | 12% | 0.59 | 61 / 504 |
brain | 13% | 103.65 | 340 / 2642 | 32% | 4.10 | 226 / 705 |
uterus | 14% | 101.25 | 24 / 170 | 19% | 2.41 | 86 / 459 |
breast | 21% | 176.86 | 95 / 459 | 9% | 0.53 | 96 / 1118 |
blood vessel | 15% | 142.22 | 201 / 1335 | 0% | 0 | 0 / 0 |
thymus | 8% | 29.24 | 50 / 653 | 7% | 0.24 | 41 / 605 |
adipose | 13% | 140.63 | 162 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 3.53 | 4 / 45 |
muscle | 8% | 36.60 | 63 / 803 | 0% | 0 | 0 / 0 |
kidney | 1% | 4.34 | 1 / 89 | 2% | 0.18 | 19 / 901 |
spleen | 0% | 1.49 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.35 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006915 | Biological process | apoptotic process |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0007601 | Biological process | visual perception |
GO_0007163 | Biological process | establishment or maintenance of cell polarity |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0030154 | Biological process | cell differentiation |
GO_0048546 | Biological process | digestive tract morphogenesis |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_2000051 | Biological process | negative regulation of non-canonical Wnt signaling pathway |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0005615 | Cellular component | extracellular space |
GO_0017147 | Molecular function | Wnt-protein binding |
Gene name | SFRP5 |
Protein name | Secreted frizzled-related protein 5 (sFRP-5) (Frizzled-related protein 1b) (FRP-1b) (Secreted apoptosis-related protein 3) (SARP-3) |
Synonyms | SARP3 FRP1B |
Description | FUNCTION: Soluble frizzled-related proteins (sFRPS) function as modulators of Wnt signaling through direct interaction with Wnts. They have a role in regulating cell growth and differentiation in specific cell types. SFRP5 may be involved in determining the polarity of photoreceptor, and perhaps, other cells in the retina. |
Accessions | Q5T4F7 ENST00000266066.4 |